BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24610537)

  • 1. Salivary bicarbonate as a major factor in the prevention of upper esophageal mucosal injury in gastroesophageal reflux disease.
    Skoczylas T; Yandrapu H; Poplawski C; Asadi M; Wallner G; Sarosiek J
    Dig Dis Sci; 2014 Oct; 59(10):2411-6. PubMed ID: 24610537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease.
    Marcinkiewicz M; Han K; Zbroch T; Poplawski C; Gramley W; Goldin G; Sarosiek J
    Am J Gastroenterol; 2000 Jul; 95(7):1652-60. PubMed ID: 10925964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effect of esophageal intraluminal mechanical and chemical stressors on salivary prostaglandin E2 in humans.
    Namiot Z; Yu ZJ; Piascik R; Hetzel DP; McCallum RW; Sarosiek J
    Am J Med Sci; 1997 Feb; 313(2):90-8. PubMed ID: 9030674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect.
    Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the secretory potential of submucosal mucous glands within the human gullet in health and disease?
    Sarosiek J; McCallum RW
    Digestion; 1995; 56 Suppl 1():15-23. PubMed ID: 7556966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis.
    Rourk RM; Namiot Z; Sarosiek J; Yu Z; McCallum RW
    Am J Gastroenterol; 1994 Feb; 89(2):237-44. PubMed ID: 8304310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease.
    Yandrapu H; Marcinkiewicz M; Poplawski C; Han K; Zbroch T; Goldin G; Sarosiek I; Namiot Z; Sarosiek J
    Am J Med Sci; 2015 May; 349(5):385-91. PubMed ID: 25789686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory impact of acid and pepsin on esophageal hydrophobicity in humans.
    DeRosa J; Marcinkiewicz M; Sarosiek J; Edmunds M; McCallum RW
    Am J Gastroenterol; 1995 Nov; 90(11):2020-4. PubMed ID: 7485014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis.
    Rourk RM; Namiot Z; Edmunds MC; Sarosiek J; Yu Z; McCallum RW
    Am J Gastroenterol; 1994 Aug; 89(8):1177-84. PubMed ID: 8053431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct salivary secretory response mediated by the esophago-salivary reflex in patients with Barrett's esophagus: its potential pathogenetic implications.
    Yandrapu H; Marcinkiewicz M; Poplawski C; Namiot Z; Zbroch T; Sarosiek J
    Adv Med Sci; 2014 Sep; 59(2):281-7. PubMed ID: 25181642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of acid and pepsin on human esophageal prostaglandins.
    Sarosiek J; Yu Z; Namiot Z; Rourk RM; Hetzel DP; McCallum RW
    Am J Gastroenterol; 1994 Apr; 89(4):588-94. PubMed ID: 8147363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do salivary organic components play a protective role in health and disease of the esophageal mucosa?
    Sarosiek J; McCallum RW
    Digestion; 1995; 56 Suppl 1():32-7. PubMed ID: 7556968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung.
    Potluri S; Friedenberg F; Parkman HP; Chang A; MacNeal R; Manus C; Bromer MQ; Malik A; Fisher RS; Nugent T; Thangada VK; Kueppers F; Miller LS
    Dig Dis Sci; 2003 Sep; 48(9):1813-7. PubMed ID: 14561007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abilities of Oropharyngeal pH Tests and Salivary Pepsin Analysis to Discriminate Between Asymptomatic Volunteers and Subjects With Symptoms of Laryngeal Irritation.
    Yadlapati R; Adkins C; Jaiyeola DM; Lidder AK; Gawron AJ; Tan BK; Shabeeb N; Price CP; Agrawal N; Ellenbogen M; Smith SS; Bove M; Pandolfino JE
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):535-542.e2. PubMed ID: 26689899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationship between esophageal challenge with mechanical and chemical stimuli and salivary protective mechanisms.
    Namiot Z; Rourk RM; Piascik R; Hetzel DP; Sarosiek J; McCallum RW
    Am J Gastroenterol; 1994 Apr; 89(4):581-7. PubMed ID: 8147362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of bicarbonate output from the intact human oesophagus.
    Brown CM; Snowdon CF; Slee B; Sandle LN; Rees WD
    Gut; 1993 Jul; 34(7):872-80. PubMed ID: 8344572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.
    Du X; Wang F; Hu Z; Wu J; Wang Z; Yan C; Zhang C; Tang J
    BMC Gastroenterol; 2017 Oct; 17(1):107. PubMed ID: 29041918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrimental impact of acid and pepsin on the rate of luminal release of transforming growth factor alpha. Its potential pathogenetic role in the development of reflux esophagitis.
    Marcinkiewicz M; Namiot Z; Edmunds MC; McCallum RW; Sarosiek J
    J Clin Gastroenterol; 1996 Dec; 23(4):261-8. PubMed ID: 8957727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease.
    Sarosiek J; Scheurich CJ; Marcinkiewicz M; McCallum RW
    Gastroenterology; 1996 Mar; 110(3):675-81. PubMed ID: 8608875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophagoprotective potential of cisapride. An additional benefit for gastroesophageal reflux disease.
    Goldin GF; Marcinkiewicz M; Zbroch T; Bityutskiy LP; McCallum RW; Sarosiek J
    Dig Dis Sci; 1997 Jul; 42(7):1362-9. PubMed ID: 9246029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.